Korean Medication Algorithm for Bipolar Disorder 2018 : Maintenance Therapy
- Author:
Jung Goo LEE
1
;
Won Myong BAHK
;
Bo Hyun YOON
;
Duk In JON
;
Jeong Seok SEO
;
Won KIM
;
Young Sup WOO
;
Jong Hyun JEONG
;
Moon Doo KIM
;
Inki SOHN
;
Se Hoon SHIM
;
Hoo Rim SONG
;
Kyung Joon MIN
Author Information
1. Department of Psychiatry, Haeundae Paik Hospital, College of Medicine, Inje University and Paik Institute for Clinical Research, Busan, Korea.
- Publication Type:Original Article
- Keywords:
Bipolar disorder;
KMAP-BP 2018;
Maintenance therapy
- MeSH:
Advisory Committees;
Antidepressive Agents;
Antipsychotic Agents;
Bipolar Disorder;
Mood Disorders;
Psychiatry
- From:
Mood and Emotion
2018;16(2):86-95
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: In this study, we evaluated the maintenance-treatment strategies of bipolar I and bipolar II disorders of KMAP-BP 2018.METHODS: The questionnaire used to survey experts for their opinions of medication used for the treatment of bipolar disorder was completed by the review committee consisting of 84 experienced psychiatrists. It is composed of 50 questions, and each question includes various sub-items. The questionnaire for maintenance treatments was composed of overall treatment strategies after acute mood episodes in bipolar I and II disorders, including the choice of antipsychotic and antidepressant drugs, duration of medication, and treatment strategies used to achieve a breakthrough in symptoms.RESULTS: In case of bipolar I disorder, mood stabilizer monotherapy, a combination of mood stabilizer and atypical antipsychotic drugs, and atypical antipsychotic drug monotherapy were the first-line treatments. In maintenance management for bipolar II disorder, combinations of mood stabilizer and mood stabilizer monotherapy or atypical antipsychotic monotherapy were preferred. Atypical antipsychotic drugs were favored as the maintenance treatment for bipolar I and II disorders in KMAP-BP 2018.CONCLUSION: There have been growing bodies of tendency that atypical antipsychotics are more preferred than previously in the KMAP-BP 2014.
